Cubist Systematic Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.94M Buy
34,200
+15,100
+79% +$2.06M 0.02% 973
2025
Q2
$2.42M Buy
19,100
+16,000
+516% +$1.96M 0.01% 1468
2025
Q1
$396K Sell
3,100
-6,600
-68% -$895K ﹤0.01% 2267
2024
Q4
$1.28M Sell
9,700
-9,100
-48% -$1.28M 0.01% 1657
2024
Q3
$2.74M Buy
18,800
+400
+2% +$57.9K 0.02% 1235
2024
Q2
$2.53M Buy
+18,400
New +$2.46M 0.02% 1181

Other funds holding IBB

Cubist Systematic Strategies's IBB Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in iShares Biotechnology ETF (IBB) in Q3 2025: 6,941 shares worth $1M. The stake represents ﹤0.01% of the portfolio and ranks #1952 among its holdings.

803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Cubist Systematic Strategies held 6,941 shares of iShares Biotechnology ETF worth $1M as of Q3 2025.
  • iShares Biotechnology ETF was a new Cubist Systematic Strategies position in Q3 2025.
  • iShares Biotechnology ETF made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1952 holding.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.